Drug
Thiocolchicoside
Thiocolchicoside is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
20%
Ph not_applicable
1
20%
Ph phase_4
3
60%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (20.0%)
Phase 43 (60.0%)
N/A1 (20.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_4
Non-Randomized Trial of Bruxism-Related TMD Treatments
NCT07586072
completednot_applicable
Evaluation of the Effects of Treatments Applied to Patients With Facial Myalgia on Occlusion Parameters
NCT05261971
completedphase_3
Efficacy Safety of a Combination Thiocolchicoside+Ketoprofen Compared to Thiocolchicoside Twice a Day for 7 Days in Patients Suffering From Acute Non Specific Low Back Pain
NCT00679146
completedphase_4
Thiocolchicoside Injection and Capsule in Treatment of Acute Low Back Pain
NCT00917436
completedphase_4
EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes
NCT00272532
Clinical Trials (5)
Showing 5 of 5 trials
NCT07586072Phase 4
Non-Randomized Trial of Bruxism-Related TMD Treatments
NCT05261971Not Applicable
Evaluation of the Effects of Treatments Applied to Patients With Facial Myalgia on Occlusion Parameters
NCT00679146Phase 3
Efficacy Safety of a Combination Thiocolchicoside+Ketoprofen Compared to Thiocolchicoside Twice a Day for 7 Days in Patients Suffering From Acute Non Specific Low Back Pain
NCT00917436Phase 4
Thiocolchicoside Injection and Capsule in Treatment of Acute Low Back Pain
NCT00272532Phase 4
EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5